RHYTHM PHARMACEUTICALS, INC.
RYTM
DELAYED 1 MONTH

7 insider filings · Latest: May 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 15, 2026May 19 8:15 PMChristopher Paul GermanCorporate Controller & CAO
Sale
4,643$92.21$428.1K0(D)

View →

Mar 4, 2026Mar 6 9:51 PMChristopher Paul GermanCorporate Controller & CAO
Sale
5,614$89.56$502.8K160(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 18, 2026May 20 8:15 PMHunter C SmithChief Financial Officer
Option Exercise
3,000$17.8779,000(D)

View →

May 15, 2026May 19 8:15 PMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
4,442$56.692,325(D)

View →

Mar 4, 2026Mar 6 9:51 PMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
1,500$17.973,731(D)

View →

Mar 2, 2026Mar 5 1:22 AMYann MazabraudEVP, Head of International
Grant/Award
35,000$94.9435,000(D)

View →

Mar 1, 2026Mar 4 12:45 AMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
1,162—1,162(D)

View →